Literature DB >> 16472868

Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.

Ryuta Saito1, Michal T Krauze, Charles O Noble, Matyas Tamas, Daryl C Drummond, Dimitri B Kirpotin, Mitchel S Berger, John W Park, Krystof S Bankiewicz.   

Abstract

Convection-enhanced delivery (CED) is a recently developed technique for local delivery of agents to a large volume of tissue in the central nervous system (CNS). We have previously reported that this technique can be applied to CNS delivery of nanoparticles including viruses and liposomes. In this paper, we describe the impact of key physical and chemical properties of infused molecules on the extent of CED-mediated delivery. For simple infusates, CED distribution was significantly increased if the infusate was more hydrophilic or had less tissue affinity. Encapsulation of tissue-affinitive molecules by neutral liposomes significantly increased their tissue distribution. The poorer brain distribution observed with cationic liposomes, due to their greater tissue affinity, was completely overcome by PEGylation, which provides steric stabilization and reduced surface charge. Finally, liposomal encapsulation of doxorubicin reduced its tissue affinity and substantially increased its distribution within brain tumor tissue. Taken together, the physical and chemical properties of drugs, small molecules and macromolecular carriers determine the tissue affinity of the infusate and strongly affect the distribution of locally applied agents. Thus, an increased and more predictable tissue distribution can be achieved by reducing the tissue affinity of the infusate using appropriately engineered liposomes or other nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472868     DOI: 10.1016/j.jneumeth.2005.12.027

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  36 in total

Review 1.  Novel delivery strategies for glioblastoma.

Authors:  Jiangbing Zhou; Kofi-Buaku Atsina; Benjamin T Himes; Garth W Strohbehn; W Mark Saltzman
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  Dynamic contrast-enhanced MRI of Gd-albumin delivery to the rat hippocampus in vivo by convection-enhanced delivery.

Authors:  Jung Hwan Kim; Garrett W Astary; Tatiana L Nobrega; Svetlana Kantorovich; Paul R Carney; Thomas H Mareci; Malisa Sarntinoranont
Journal:  J Neurosci Methods       Date:  2012-06-08       Impact factor: 2.390

Review 3.  Real-time imaging and quantification of brain delivery of liposomes.

Authors:  Michal T Krauze; John Forsayeth; John W Park; Krystof S Bankiewicz
Journal:  Pharm Res       Date:  2006-09-14       Impact factor: 4.200

Review 4.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

5.  Voxelized computational model for convection-enhanced delivery in the rat ventral hippocampus: comparison with in vivo MR experimental studies.

Authors:  Jung Hwan Kim; Garrett W Astary; Svetlana Kantorovich; Thomas H Mareci; Paul R Carney; Malisa Sarntinoranont
Journal:  Ann Biomed Eng       Date:  2012-04-25       Impact factor: 3.934

6.  Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.

Authors:  Ryuta Saito; Michal T Krauze; Charles O Noble; Daryl C Drummond; Dmitri B Kirpotin; Mitchel S Berger; John W Park; Krystof S Bankiewicz
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

Review 7.  The status of gene therapy for brain tumors.

Authors:  Giulia Fulci; E Antonio Chiocca
Journal:  Expert Opin Biol Ther       Date:  2007-02       Impact factor: 4.388

8.  Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles.

Authors:  Keith B Neeves; Andrew J Sawyer; Conor P Foley; W Mark Saltzman; William L Olbricht
Journal:  Brain Res       Date:  2007-08-29       Impact factor: 3.252

Review 9.  Convection-enhanced delivery for the treatment of brain tumors.

Authors:  Waldemar Debinski; Stephen B Tatter
Journal:  Expert Rev Neurother       Date:  2009-10       Impact factor: 4.618

10.  Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.

Authors:  Amy Y Grahn; Krystof S Bankiewicz; Millicent Dugich-Djordjevic; John R Bringas; Piotr Hadaczek; Greg A Johnson; Simon Eastman; Matthias Luz
Journal:  J Neurooncol       Date:  2009-05-24       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.